D Lesieur1, V Leclerc, P Chavatte
1Institut de Chimie Pharmaceutique, Université de Lille II, France.
Melatonin serves as a lead compound for drug design. Researchers modified its structure to understand receptor interactions, leading to potential new drugs and pharmacological tools.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: